SCHEDULE: Gabelli Funds Group Exits ZimVie Stake Post-Archimed Acquisition
Amendment to Beneficial Ownership Statement (Schedule 13D/A)
A group of investment entities led by Mario Gabelli has ceased beneficial ownership of ZimVie Inc. common stock following the completion of its acquisition by ARCHIMED.
Summary
- Reporting Persons, including GAMCO Investors, Inc. and Gabelli Funds, LLC, no longer hold beneficial ownership of ZimVie Inc. common stock.
- The cessation of ownership occurred on October 20, 2025, due to the completion of ZimVie Inc.'s acquisition by ARCHIMED.
- Prior to the acquisition, various Gabelli-affiliated funds executed sales of ZimVie shares on October 20, 2025, at a price of $19.0000 per share.
- Transactions in the sixty days preceding the filing also included both purchases and sales of ZimVie shares by Gabelli & Company Investment Advisers, Inc., Gabelli Funds, LLC, GAMCO Asset Management Inc., and Mario J. Gabelli, with prices ranging from $18.8500 to $18.9839 per share for purchases and $18.8600 to $18.9900 for sales prior to the final acquisition sales.
- The aggregate amount beneficially owned by each reporting person is now 0.00 shares, representing 0.0% of the class.
Sentiment
Score: 5
Explanation: The filing is neutral as it reports a factual event (completion of an acquisition and subsequent divestment of shares) without expressing a positive or negative outlook on the issuer or the transaction itself from the perspective of the reporting persons.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding ZimVie Inc.'s future operations or financial performance, as it pertains to the cessation of beneficial ownership by the Reporting Persons following an acquisition.
Industry Context
The filing reflects a change in ownership structure for ZimVie Inc. as it transitions from a publicly traded entity to a privately held company under ARCHIMED's ownership. This is a common occurrence in the healthcare and medical device industry, where private equity firms often acquire public companies to drive strategic changes or operational efficiencies away from public market scrutiny.
Stakeholder Impact
- Shareholders of ZimVie Inc. (prior to the acquisition) received $19.00 per share as part of the ARCHIMED acquisition.
- The Reporting Persons (Gabelli-affiliated entities) have fully divested their stake in ZimVie Inc.
Key Dates
| Date | Description |
|---|---|
| 2025-08-25 | Various Gabelli-affiliated funds purchased ZimVie shares. |
| 2025-08-26 | Various Gabelli-affiliated funds purchased ZimVie shares. |
| 2025-08-27 | Various Gabelli-affiliated funds purchased ZimVie shares. |
| 2025-08-28 | Various Gabelli-affiliated funds purchased ZimVie shares. |
| 2025-08-29 | Various Gabelli-affiliated funds purchased ZimVie shares. |
| 2025-09-02 | GAMCO Asset Management Inc. sold ZimVie shares. |
| 2025-09-03 | Gabelli Global Mini Mites Fund sold ZimVie shares. |
| 2025-09-04 | GAMCO Asset Management Inc. sold ZimVie shares. |
| 2025-09-05 | Gabelli Equity Income Fund sold ZimVie shares; GDL Fund purchased ZimVie shares. |
| 2025-09-09 | GDL Fund purchased ZimVie shares. |
| 2025-09-10 | GDL Fund purchased ZimVie shares. |
| 2025-09-11 | GDL Fund purchased ZimVie shares. |
| 2025-09-12 | GAMCO Asset Management Inc. sold ZimVie shares. |
| 2025-09-18 | GAMCO Asset Management Inc. sold ZimVie shares. |
| 2025-09-23 | GAMCO Asset Management Inc. sold ZimVie shares. |
| 2025-09-26 | GAMCO Asset Management Inc. sold ZimVie shares. |
| 2025-09-29 | GDL Fund purchased ZimVie shares. |
| 2025-10-06 | GAMCO Asset Management Inc. sold ZimVie shares. |
| 2025-10-09 | GAMCO Asset Management Inc. sold ZimVie shares. |
| 2025-10-10 | Gabelli ABC Fund purchased ZimVie shares. |
| 2025-10-20 | Completion of the acquisition of ZimVie Inc. by ARCHIMED, resulting in the sale of all remaining shares by Reporting Persons and cessation of beneficial ownership. |
| 2025-10-22 | Date of filing of this Schedule 13D Amendment No. 1. |
Keywords
ZimVie Inc., ARCHIMED, Acquisition, Beneficial Ownership, Schedule 13D, GAMCO Investors, Gabelli Funds, Common Stock, Divestment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.